[HTML][HTML] Topical loperamide-encapsulated liposomal gel increases the severity of inflammation and accelerates disease progression in the adjuvant-induced model of …

S Hua, TH Dias, DG Pepperall, Y Yang - Frontiers in Pharmacology, 2017 - frontiersin.org
This study evaluates the prophylactic effect of the peripherally-selective mu-opioid receptor
agonist, loperamide, administered topically in a liposomal gel formulation on pain …

Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced Model of …

S Hua, TH Dias, DG Pepperall… - Frontiers in …, 2017 - pubmed.ncbi.nlm.nih.gov
This study evaluates the prophylactic effect of the peripherally-selective mu-opioid receptor
agonist, loperamide, administered topically in a liposomal gel formulation on pain …

[HTML][HTML] Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced …

S Hua, TH Dias, DG Pepperall… - Frontiers in Pharmacology, 2017 - ncbi.nlm.nih.gov
This study evaluates the prophylactic effect of the peripherally-selective mu-opioid receptor
agonist, loperamide, administered topically in a liposomal gel formulation on pain …

[PDF][PDF] Susan Hua*, Thilani H. Dias, Debbie-Gai Pepperall1 and Yuan Yang 3

PB Osborne, M Morgan, V Fernández-Dueñas, S Hua… - nova.newcastle.edu.au
This study evaluates the prophylactic effect of the peripherally-selective mu-opioid receptor
agonist, loperamide, administered topically in a liposomal gel formulation on pain …

Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced Model of …

S Hua, TH Dias, DG Pepperall, Y Yang - Frontiers in Pharmacology, 2017 - europepmc.org
This study evaluates the prophylactic effect of the peripherally-selective mu-opioid receptor
agonist, loperamide, administered topically in a liposomal gel formulation on pain …

[HTML][HTML] Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced …

S Hua, TH Dias, DG Pepperall, Y Yang - Frontiers in Pharmacology, 2017 - frontiersin.org
This study evaluates the prophylactic effect of the peripherally-selective mu-opioid receptor
agonist, loperamide, administered topically in a liposomal gel formulation on pain …